HOME >> BIOLOGY >> NEWS
Cancer could be caught before it develops

An article published in the journal BMC Medical Informatics and Decision Making describes the creation of the first comprehensive listing and classification of precancers, drawn from the medical literature. Using this classification, the precancers have been organized into groups that share similar biologic profiles and, hopefully, similar treatments.

Precancers precede invasive cancers. They are localized changes in tissue lesions - identifiable by their morphologic structure. During carcinogenesis, when normal cells are transformed into cancerous cells, it is possible to identify precancers. Treating or removing precancerous cells at this early stage could prevent the prolonged, painful treatment and deaths of cancer sufferers. According to the authors of the article,

"Premalignant lesions are arguably the most important disease entities of modern man. In theory, the successful treatment of precancers would result in the eradication of most human cancers."

Despite their importance, until now there has been no attempt to produce a list of precancers, or to classify them according to their biological properties. Jules Berman of the National Cancer Institute at the NIH, and Donald Henson of George Washington University, Washington D.C., have produced a first draft of such a classification, which can be downloaded from http://65.222.228.150/jjb/presum.tar.gz. Berman and Henson worked from the National Library of Medicine's Unified Medical Language System (UMLS), extracting all of the terms relating to precancers from the 'Metathesaurus', and adding an additional 10% from their own knowledge. They identified 568 distinct precancer 'concepts', which have been described by over 4700 terms. Often one precancer is described in many different ways, and can have a number of terms that refer to it. The database includes terms from seven languages in addition to English terms.

Preca
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
20-Jun-2003


Page: 1 2

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Cancer gene MYC emerging as key research target
5. Cancer patient, heal thyself
6. USC researcher named General Motors Cancer Research Scholar
7. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
8. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
9. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
10. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
11. National Cancer Gene Therapy Foundation gives $4.0 million in research grants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... ... September 10, 2018 , ... IONpathTM, a venture-backed commercial-stage pathology ... Ion Beam Imaging (MIBITM) technology was accepted by the journal Cell and will ... during a webinar presented by Dr. Mike Angelo on October 2nd, 2018. ...
(Date:9/12/2018)... ... September 12, 2018 , ... Captiva ... announced today it has received 510(k) clearance from the U.S. Food and Drug ... MIS Pedicle Screw System. , TowerLOX-EXT MIS Extended Tab Pedicle Screws provide the ...
(Date:9/7/2018)... , ... September 06, 2018 , ... ... Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its complete ... related to the spine that result from it. The deal will make CTL ...
Breaking Biology News(10 mins):
(Date:8/26/2018)... Korea (PRWEB) , ... August 24, 2018 , ... ... paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a ... , According to the paper, the symptoms of mice having severe atopic ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... medical device compliance and commercialization, has just released a new paper discussing ... presented by Dr. Mario Kossmann, ESEP at the 28th Annual INCOSE International ...
(Date:8/17/2018)... ... 16, 2018 , ... KCAS Bioanalytical and Biomarker Services, a ... their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of BioPharma. , ... that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. Dr. Dufield ...
(Date:8/14/2018)... ... August 13, 2018 , ... ... fume hoods and biological safety cabinets. In addition, Labconco produces other lab equipment, ... measure of its commitment to quality and consistency in design and manufacturing. ...
Breaking Biology Technology:
Cached News: